Skip to main content
SGMT
NASDAQ Life Sciences

FDA Clears Sagimet's IND for Phase 3 Acne Trial, Paving Way for H2 2026 Start

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$9.47
Mkt Cap
$574.521M
52W Low
$4.5
52W High
$10.062
52W Position info
110% above low
Off High info
5.9% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

SGMT has more than doubled off its 52-week low of $4.5.

Summary

Sagimet received FDA 'Study May Proceed' clearance for its IND on denifanstat in moderate to severe acne, allowing the Phase 3 trial to initiate in H2 2026. This follows the Q2 2026 results and strategic pivot toward acne, with $257.6M in cash funding operations through the trial. The clearance removes a key regulatory hurdle and validates the acne program's path forward. The Phase 3 trial start is now confirmed for the second half of 2026.

At the time of this announcement, SGMT was trading at $9.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $574.5M. The 52-week trading range was $4.50 to $10.06. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

SGMT - Latest Insights

SGMT
Nov 12, 2026, 7:32 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.40
Real-time Price: $10.66 info
Change: -$0.7417 (-7%) info
Market Cap: $768.829M info
SGMT
Nov 12, 2026, 7:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.40
Real-time Price: $10.66 info
Change: -$0.7417 (-7%) info
Market Cap: $768.829M info
SGMT
Oct 01, 2026, 5:41 PM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $10.66 info
Change: +$1.42 (+15%) info
Market Cap: $768.829M info
SGMT
Sep 30, 2026, 6:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.03
Real-time Price: $10.66 info
Change: +$0.6283 (+6%) info
Market Cap: $768.829M info
SGMT
Sep 30, 2026, 5:53 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $10.03
Real-time Price: $10.66 info
Change: +$0.6283 (+6%) info
Market Cap: $768.829M info